Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
Debiopharm granted exclusive global rights to use Genome & Company’s antibodies to develop potential first-in-class…
Debiopharm granted exclusive global rights to use Genome & Company’s antibodies to develop potential first-in-class…
SAN DIEGO--(BUSINESS WIRE)--#WGS--Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge…
HONG KONG SAR - Media OutReach Newswire - 3 June 2024 - Black Spade Capital…
Generation Mining Hosting Fireside Chat with Report Co-Author TORONTO--(BUSINESS WIRE)--$genm #copper--Generation Mining Limited (TSX:GENM, OTCQB:…
– Phase 2b Trial Demonstrated Statistically Significant and Clinically Meaningful Improvements Across Primary and all…
The highest tier of its kind designed exclusively for high-net-worth customers HONG KONG SAR -…
The revitalized court and upcoming coach education workshop is the latest in a six-country series…
SINGAPORE - Media OutReach Newswire - 3 June 2024 - Confidence Funeral Services Pte Ltd…
HONG KONG SAR - Media OutReach Newswire - 3 June 2024 - Immuno Cure BioTech…
TAIPEI--(BUSINESS WIRE)--#ACCEVOLUTION--Renowned globally for its research and development capabilities, GIGABYTE Technology will exhibit its products…